Patents by Inventor Ib Clausen

Ib Clausen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070154988
    Abstract: A Bacillus licheniformis mutant host cell derived from a parent B. licheniformis host cell, which mutant host cell is mutated in one or more gene(s) encoding one or more polypeptide(s) involved in sporulation which is at least 80% identical to one or more of the polypeptides shown in SEQ ID NO's: 2 to 191, wherein the mutant host cell expresses at least 5% less of the one or more polypeptide(s) involved in sporulation than the parent host cell, when they are cultivated under comparable conditions.
    Type: Application
    Filed: December 15, 2006
    Publication date: July 5, 2007
    Applicant: Novozymes A/S
    Inventors: Jens Andersen, Steen Jorgensen, Michael Rasmussen, Peter Olsen, Ib Clausen
  • Publication number: 20070015168
    Abstract: The present invention relates to methods for monitoring differential expression of a plurality of genes in a first Bacillus cell relative to expression of the same genes in one or more second Bacillus cells using microarrays containing Bacillus genomic sequenced tags. The present invention also relates to computer readable media and computer-based systems. The present invention further relates to substrates containing an array of Bacillus licheniformis or Bacillus clausii GSTs.
    Type: Application
    Filed: August 12, 2005
    Publication date: January 18, 2007
    Applicants: Novozymes A/S, Novozymes, Inc.
    Inventors: Alexandre Bolotine, Alexei Sorokine, Alla Lapidus, Randy Berka, Ib Clausen
  • Publication number: 20060040346
    Abstract: A Bacillus licheniformis mutant host cell derived from a parent B. licheniformis host cell, which mutant host cell is mutated in one or more gene(s) encoding one or more polypeptide(s) involved in antibiotic synthesis which is at least 80% identical to one or more of the polypeptides shown in SEQ ID NO's: 2 to 22, wherein the mutant host cell expresses at least 5% less of the one or more polypeptide(s) involved in antibiotic synthesis than the parent host cell, when they are cultivated under comparable conditions.
    Type: Application
    Filed: March 25, 2003
    Publication date: February 23, 2006
    Applicant: Novozymes A/S
    Inventors: Jens Andersen, Steen Jorgensen, Michael Rasmussen, Peter Olsen, Ib Clausen
  • Publication number: 20050244922
    Abstract: A Bacillus licheniformis mutant host cell derived from a parent B. licheniformis host cell, which mutant host cell is mutated in one or more gene(s) encoding one or more secreted polypeptide(s) which is at least 80% identical to one or more of the polypeptides shown in SEQ ID NO's: 2 to 248, wherein the mutant host cell secretes at least 5% less of the one or more secreted polypeptide(s) than the parent host cell, when they are cultivated under comparable conditions.
    Type: Application
    Filed: March 25, 2003
    Publication date: November 3, 2005
    Inventors: Jens Andersen, Steen Jorgensen, Michael Rasmussen, Peter Olsen, Ib Clausen
  • Publication number: 20050221423
    Abstract: A Bacillus licheniformis mutant host cell derived from a parent B. licheniformis host cell, which mutant host cell is mutated in one or more gene(s) encoding one or more polypeptide(s) involved in sporulation which is at least 80% identical to one or more of the polypeptides shown in SEQ ID NO's: 2 to 191, wherein the mutant host cell expresses at least 5% less of the one or more polypeptide(s) involved in sporulation than the parent host cell, when they are cultivated under comparable conditions.
    Type: Application
    Filed: March 25, 2003
    Publication date: October 6, 2005
    Inventors: Jens Andersen, Steen Jorgensen, Michael Rasmussen, Peter Olsen, Ib Clausen
  • Publication number: 20050176097
    Abstract: A Bacillus licheniformis mutant host cell comprising a mutation (deletion) in one or more genes encoding polypeptides having proteolytic activity wherein the mutant host cell expresses at least 5% less of the one or more proteases than the parent host cell, when cultivated under comparable conditions. The mutant host cell is used for producing heterologous polypeptides.
    Type: Application
    Filed: March 25, 2003
    Publication date: August 11, 2005
    Inventors: Jens Andersen, Steen Jorgensen, Michael Rasmussen, Peter Olsen, Ib Clausen